CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...